Form 8-K - Current report:
SEC Accession No. 0001628280-21-009844
Filing Date
2021-05-11
Accepted
2021-05-11 17:15:23
Documents
3
Period of Report
2021-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2021q18k-earningsrelease.htm 8-K 31321
2 EX-99.1 a2021q1-ex991earningsrelea.htm EX-99.1 201907
3 cumberlandpharmaimageaa061a.jpg GRAPHIC 37721
  Complete submission text file 0001628280-21-009844.txt   286433
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 21912444
SIC: 2834 Pharmaceutical Preparations